ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | +166.7% | 40,603 | +250.3% | 0.00% | – |
| Q2 2022 | $3,000 | -75.0% | 11,592 | -73.0% | 0.00% | – |
| Q1 2022 | $12,000 | -50.0% | 42,915 | +82.7% | 0.00% | -100.0% |
| Q3 2021 | $24,000 | -35.1% | 23,493 | +120.2% | 0.00% | – |
| Q1 2019 | $37,000 | +19.4% | 10,669 | -28.2% | 0.00% | – |
| Q1 2018 | $31,000 | -56.9% | 14,867 | -58.3% | 0.00% | -100.0% |
| Q4 2017 | $72,000 | -8.9% | 35,676 | +109.0% | 0.00% | -71.4% |
| Q3 2017 | $79,000 | +71.7% | 17,073 | -2.5% | 0.01% | -53.3% |
| Q4 2016 | $46,000 | +9.5% | 17,517 | +28.9% | 0.02% | -72.2% |
| Q1 2016 | $42,000 | – | 13,594 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |